Entering the Irish market last week, Actavis plans to create up to 25 new local jobs over the next five years and to launch more
Tag: Gemcitabine
Actavis launches Gemcitabine on patent expiry in EU markets
The international generic pharmaceuticals company, Actavis Group, has launched the oncology product Gemcitabine in EU markets, at patent expiry. This launch represents a significant milestone
